Benzinga's Cannabis Capital Conference, a seasonal gathering of budding entrepreneurs, capital interests and insightful industry involvements, provides perspective on where innovations may lead and how they can be funded. This particular event features speakers and panelists addressing issues in the cannabis space as well as presentations from more than 30 cannabis companies.
For more information visit:
- 4Front Ventures Corp.
- Ayr Wellness Inc.
- Charlotte's Web Holdings Inc.
- Christina Lake Cannabis Corp.
- Columbia Care Inc.
- Curaleaf Holdings Inc.
- Delic Holdings Inc.
- Delta 9 Cannabis Inc.
- Greater Cannabis Company Inc.
- HempFusion Wellness Inc.
- Indus Holdings Inc.
- Item 9 Labs Corp.
- Jushi Holdings Inc.
- Khiron Life Sciences Corp.
- KushCo Holdings Inc.
- MagicMed Industries Inc.
- Massroots Inc.
- Mydecine Innovations Group Inc.
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands, including Marmas, Crystal Clear, Funky Monkey, Pebbles and the Pure Ratios wellness collection, distributed through retail outlets and the company's chain of strategically positioned Mission-branded dispensaries. For more information, visit the company's website at www.4frontventures.com
Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) is an expanding vertically integrated, U.S. multi-state cannabis operator focused on delivering the highest quality cannabis products and customer experience throughout its footprint. Based on the belief that everything starts with the quality of the plant, the company is focused on superior cultivation to grow superior branded cannabis products. Ayr strives to enrich consumers' experience every day through the wellness and wonder of cannabis. For more information, visit the company's website at www.ayrwellness.com
Charlotte's Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) is the market leader in the production and distribution of innovative hemp-derived cannabidiol ("CBD") wellness products under a family of brands which includes Charlotte's Web™, CBD Medic™, CBD Clinic™ and Harmony Hemp. The company's premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into whole-plant hemp extracts containing a full spectrum of naturally occurring phytocannabinoids, including CBD, CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, stress, inflammation recovery), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. For more information, visit the company's website at www.charlottesweb.com
Christina Lake Cannabis Corp. (CSE: CLC)
Christina Lake Cannabis Corp. (CSE: CLC) is a licensed producer of cannabis. It has secured a standard cultivation license and corresponding processing/sales amendment from Health Canada, as well as a research and development license. CLC's facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and, in its inaugural harvest year, produced 32,500 kg (71,650 lb.) on its existing facility before developing an adjacent 99-acre expansion property. For more information, visit the company's website at www.christinalakecannabis.com
Columbia Care Inc. (CSE: CCHW) (OTCQX: CCHWF) is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care currently operates 108 facilities, including 81 dispensaries and 27 cultivation and manufacturing facilities. Columbia Care is one of the original providers of medical cannabis in the United States, and it continues to deliver an industry-leading, patient-centered medicinal cannabis operation that has quickly expanded into the adult use market as a premier operator. The company currently offers products spanning flower, edibles, oils and tablets, and it manufactures popular brands including Seed & Strain, Amber and Platinum Label CBD. For more information, visit the company's website at www.col-care.com
Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) is a leading U.S. provider of consumer products in cannabis, with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a vertically integrated, high-growth cannabis operator known for quality, expertise and reliability, the company and its brands, including Curaleaf, Select and Grassroots, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 101 dispensaries, 23 cultivation sites and over 30 processing sites, and it employs over 3,800 team members across the United States. For more information, visit the company's website at www.curaleaf.com
Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) was formed in 2019 to address the growing interest in psychedelic wellness backed by science. DELIC was the first psychedelic umbrella platform and is currently a trusted source for those interested in psychedelic culture, psychedelic clinics and more. DELIC's offerings include Ketamine Infusion Center, a limited liability corporation formed under the laws of Arizona that runs two ketamine clinics in Arizona and California; 'Reality Sandwich', a free public education platform providing psychedelic guides, news and culture; 'Meet Delic', the first ever psychedelic wellness summit; and 'The Delic', an e-commerce lifestyle brand. For more information, visit the company's website at www.deliccorp.com
Delta 9 Cannabis Inc. (TSX: DN) (OTCQX: VRNDF) is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. For more information, visit the company's website at www.delta9.ca
Greater Cannabis Company Inc. (OTC: GCAN)
Greater Cannabis Company Inc. (OTC: GCAN) is a fully reporting publicly traded biopharmaceutical company focused on the development and commercialization of innovative cannabinoid delivery systems. Greater Cannabis deploys its technology platform for use in the cannabis industry. The company's conveyance platform can be utilized to deliver cannabinoids without the harmful side effects found with other routes of cannabinoid administration. The technology is versatile in that patients can receive lower dosing, enhanced bioavailability and controlled rapid and delayed release using non-irritant oral eluting and transdermal patches. Greater Cannabis' mission is to bring its technology to the global market through partnerships with leading cannabis and pharmaceutical companies, for the benefit of patients and consumers. For more information, visit the company's website at www.gcanrx.com
HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion's diverse product portfolio comprises 48 SKUs including tinctures, OTC topicals, doctor/practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion's wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. For more information, visit the company's website at www.hempfusion.com
Indus Holdings Inc. (CSE: INDS) (OTCQX: INDXF) is a vertically integrated cannabis company with advanced production capabilities, including cultivation, extraction, manufacturing, brand sales & marketing, and distribution. Founded in 2014 and based in Salinas, California, Indus offers services supporting every step of the supply chain and an extensive portfolio of award-winning brands, including Cypress Cannabis, House Weed, The Original Pot Co., MOON, Humble Flower and Kaizen Medicinals. Indus Distribution, a division of Indus Holdings Inc., is a leading distributor of cannabis products, servicing an extensive portfolio of brands and licensed retailers. For more information, visit the company's website at www.indusholdingsinc.com
Item 9 Labs Corp. (OTCQX: INLB)
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities and production innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector and capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For more information, visit the company's website at www.item9labscorp.com
Jushi Holdings Inc. (CSE: JUSH) (OTCQB: JUSHF) is a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit the company's website at www.jushico.com
Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF) is a vertically integrated medical and CPG cannabis company with core operations in Latin America and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low- and high-THC medical cannabis products. The company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and it is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021. For more information, visit the company's website at www.khiron.ca
KushCo Holdings Inc. (OTCQX: KSHB)
KushCo Holdings Inc. (OTCQX: KSHB) is a premier provider of ancillary products and services to the legal cannabis and CBD industries. KushCo Holdings' subsidiaries and brands provide product quality, exceptional customer service, compliance knowledge and a local presence in serving its diverse customer base, which consists of leading multi-state-operators (MSOs), licensed producers (LPs) and brands. Founded in 2010, KushCo Holdings has now sold more than 1 billion units to growers, brand owners, processors and producers across North America, South America and Europe, specializing in child-resistant compatible and fully customizable packaging, exclusive vape hardware and technology, and complementary solvents and natural products. For more information, visit the company's website at www.kushco.com
MagicMed Industries Inc. (CSE: MGIC - Reserved)
MagicMed Industries Inc. (CSE: MGIC - Reserved) is a biotechnology company founded in 2020. The company is focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed's molecular derivatives library, the Psybrary™, is intended to be an essential building block from which industry partners can develop new patented products. MagicMed is focused on the discovery and early development of novel drug candidates, structurally related to the classic psychedelics but with vastly improved pharmaceutical characteristics and commercial potential. To create the novel derivatives contained in the Psybrary™, the MagicMed team combines synthetic biology and traditional chemistry techniques. This combination allows MagicMed to create a library of molecules that is larger and more diverse than what chemistry techniques alone can achieve. MagicMed analyzes, catalogues, and stores the molecules to find desired characteristics, such as an improved safety profile. Screening a vast library of drug candidates generates a sizeable amount of data that can be processed and used to improve future generations of the Psybrary™. For more information, visit the company's website at www.magicmedindustries.com
Massroots Inc. (OTC: MSRT)
Massroots Inc. (OTC: MSRT) is a leading media company focused on the regulated cannabis industry, with a significant following and traffic across its online and social media platforms. MassRoots has been covered by CNBC, CNN, Financial Times, Wall Street Journal, New York Times, Reuters, Associated Press and Forbes. For more information, visit the company's website at www.massrootsinvestors.com
Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) is an emerging biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. The company's world-renowned medical and scientific advisory board is building out a robust R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols and unique delivery systems. Mydecine has exclusive access to a full cGMP-certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate and analyze active mushroom compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, Colorado, to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms. For more information, visit the company's website at www.mydecine.com
Novamind Inc. (CSE: NM)
Novamind Inc. (CSE: NM) is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information, visit the company's website at www.novamind.ca
Skye Bioscience Inc. (OTCQB: SKYE)
Skye Bioscience Inc. (OTCQB: SKYE) is a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet needs. The company's lead molecule, in preclinical studies, has demonstrated potential as a new class of therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs. For more information, visit the company's website at www.skyebioscience.com
SLANG Worldwide Inc. (CSE: SLNG) (OTCQB: SLGWF) is a global leader in the cannabis CPG sector with a diversified portfolio of popular brands distributed across the United States. The company specializes in acquiring and developing market-proven regional brands, as well as launching innovative new brands to seize global market opportunities. For more information, visit the company's website at www.slangww.com
Stem Holdings Inc. (CSE: STEM) (OTCQX: STMH) is a leading omnichannel, vertically integrated cannabis branded products and technology company with state-of-the-art cultivation, processing, extraction, retail, distribution and delivery-as-a-service (DaaS) operations throughout the United States. Stem's family of award-winning brands includes TJ's Gardens™, TravisxJames™ and Yerba Buena™ flower and extracts; Cannavore™ edible confections; Doseology™, a CBD mass-market brand launching in 2021; and DaaS brands Budee™ and Ganjarunner™ through the acquisition of Driven Deliveries. Budee and Ganjarunner e-commerce platforms provide direct-to-consumer proprietary logistics and an omnichannel UX (user experience) / CX (customer experience). For more information, visit the company's website at www.stemholdings.com
TILT Holdings Inc. (CSE: TILT) (OTCQX: TLLTF) helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT's core businesses include Jupiter, a wholly owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations CAC in Massachusetts and Standard Farms in Pennsylvania. TILT is headquartered in Phoenix, Arizona. For more information, visit the company's website at www.tiltholdings.com
The Parent Company (TPCO Holding Corp.) (OTCQX: GRAMF)
The Parent Company (TPCO Holding Corp.) (OTCQX: GRAMF) is California's leading vertically integrated cannabis company, combining best-in-class operations with leading voices in popular culture and social impact. The Parent Company brings together global icon and entrepreneur Shawn "Jay-Z" Carter, entertainment powerhouse Roc Nation, leading California direct-to-consumer platform Caliva, and leading cannabis and hemp manufacturer Left Coast Ventures to form a cannabis industry leader for the post-prohibition era. Chief Visionary Officer Shawn "Jay-Z" Carter will guide The Parent Company's brand strategy in partnership with Roc Nation, the world's preeminent entertainment company with a roster of culture-making artists, athletes and influencers. For more information, visit the company's website at www.theparent.co
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) is primarily a vertically integrated "seed-to-sale" company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also has operations in California, Massachusetts, Connecticut and Pennsylvania. For more information, visit the company's website at www.trulieve.com
Turning Point Brands Inc. (NYSE: TPB)
Turning Point Brands Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients through its iconic core brands, Zig-Zag® and Stoker's®, and its emerging brands within the NewGen segment. TPB's products are available in more than 210,000 retail outlets in North America in addition to certain websites. For more information, visit the company's website at www.turningpointbrands.com
Zoned Properties Inc. (OTCQB: ZDPY)
Zoned Properties Inc. (OTCQB: ZDPY) is a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for clients in the regulated cannabis industry, positioning the company for real estate acquisitions and revenue growth. Zoned Properties intends to pioneer sustainable development for emerging industries, including the regulated cannabis industry. The company is an accredited member of the Better Business Bureau, the U.S. Green Building Council and the Forbes Real Estate Council. It is focused on investing capital to acquire and develop commercial properties to be leased on a triple-net basis, as well as engaging clients that face zoning, permitting, development and operational challenges. For more information, visit the company's website at www.zonedproperties.com